跳至主要内容
临床试验/CTRI/2025/11/097630
CTRI/2025/11/097630尚未招募不适用

A study on the efficacy of Individualized Homoeopathic Medicines combined with Cognitive Behavioural Therapy in Adult ADHD

Department of Organon of Medicine, White Memorial Homoeo Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Change in total ADHD symptom severity scores (Quantified ASRS) from baseline to 12 months.

研究概览

简要总结

Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental disorder was first identified in children but is now more widely acknowledged in adults. Risks of untreated ADHD may result in difficulties with impulse control, attention, and executive functions, impacting various aspects of an individual’s life. Adult ADHD symptoms are similar to those of childhood ADHD, albeit over time, the severity of some symptoms, particularly hyperactivity, may lessen. There is a lack of scientific research on psychosocial treatments, however there is some initial evidence that cognitive behavioural therapy and medicine work well together.  Cognitive Behavioural Therapy (CBT) is evidence-based and effective in improving coping mechanisms, emotional control, and functional skills. The long-term use of pharmacological agents may be associated with side effects, dependency concerns, and poor adherence. The need to investigate safe, cost-effective, and integrative treatment options that improve quality of life and functional outcomes is urgent, given the growing number of adults experiencing symptoms of ADHD and the shortcomings of pharmaceutical treatments. A potentially comprehensive and patient-centred strategy is provided by combining homeopathy with structured Cognitive Behavioural Therapy. Through the use of standardized instruments (such as the ASRS v1.1) and a scientifically sound format, this study seeks to close a substantial research gap by comparing the efficacy of individualized homeopathic treatment with CBT. This study will evaluate whether homeopathy can effectively manage ADHD in addition to or instead of traditional treatment by comparing changes in symptom severity over a 12-month period. The study also aims to compare Quality of life before and after the study using WHOQOL- BREF Scale.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Adults between the ages 18 to 45 years Diagnosis of ADHD or positive screening on ASRS v1 1 Willingness to undergo either homeopathic treatment or with CBT Ability to provide informed consent Able to participate in follow-up over 12 months.

排除标准

  • Age below 18 and above
  • Presence of major psychiatric disorders (bipolar disorder, schizophrenia).
  • Autism spectrum disorder (ASD) (unless ADHD symptoms are clearly present and separate).
  • Currently under pharmacological treatment for ADHD.
  • Current substance dependence.
  • Unwillingness or inability to commit to follow-up.

结局指标

主要结局

Change in total ADHD symptom severity scores (Quantified ASRS) from baseline to 12 months.

时间窗: Assessment is done at beginning of study, at 6th month and at 12th month.

次要结局

  • Change in Quality of life score assessed by WHOQOL- BREF scale.(Assessment is done at beginning of study and at 12th month.)

研究者

发起方
Department of Organon of Medicine, White Memorial Homoeo Medical College and Hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Soubhagya S S

White Memorial Homoeo Medical College and Hospital

研究点 (1)

Loading locations...

相似试验